Human Gene ITGAL (ENST00000356798.11_4) from GENCODE V47lift37
Description: integrin subunit alpha L, transcript variant 1 (from RefSeq NM_002209.3)
Gencode Transcript: ENST00000356798.11_4
Gencode Gene: ENSG00000005844.19_16
Transcript (Including UTRs)
Position: hg19 chr16:30,484,063-30,534,506 Size: 50,444 Total Exon Count: 31 Strand: +
Coding Region
Position: hg19 chr16:30,484,159-30,532,986 Size: 48,828 Coding Exon Count: 31
Data last updated at UCSC: 2024-08-22 23:36:26
Sequence and Links to Tools and Databases
Comments and Description Text from UniProtKB
ID: ITAL_HUMAN
DESCRIPTION: RecName: Full=Integrin alpha-L; AltName: Full=CD11 antigen-like family member A; AltName: Full=Leukocyte adhesion glycoprotein LFA-1 alpha chain; Short=LFA-1A; AltName: Full=Leukocyte function-associated molecule 1 alpha chain; AltName: CD_antigen=CD11a; Flags: Precursor;
FUNCTION: Integrin alpha-L/beta-2 is a receptor for ICAM1, ICAM2, ICAM3 and ICAM4. It is involved in a variety of immune phenomena including leukocyte-endothelial cell interaction, cytotoxic T-cell mediated killing, and antibody dependent killing by granulocytes and monocytes.SUBUNIT: Heterodimer of an alpha and a beta subunit. Alpha-L associates with beta-2.SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.TISSUE SPECIFICITY: Leukocytes.DOMAIN: The integrin I-domain (insert) is a VWFA domain. Integrins with I-domains do not undergo protease cleavage.SIMILARITY: Belongs to the integrin alpha chain family.SIMILARITY: Contains 7 FG-GAP repeats.SIMILARITY: Contains 1 VWFA domain.WEB RESOURCE: Name=NIEHS-SNPs; URL="http://egp.gs.washington.edu/data/itgal/";
Primer design for this transcript
MalaCards Disease Associations
MalaCards Gene Search: ITGAL
Diseases sorted by gene-association score: benign cephalic histiocytosis (8), leukocyte adhesion deficiency (6), lichen planus (4), rheumatoid arthritis (3), mycosis fungoides (3), guttate psoriasis (3), hashimoto thyroiditis (3), autoimmune enteropathy (3), lymphocytic vasculitis (3), actinic prurigo (2), pustulosis palmaris et plantaris (2), cardiomyopathy (2), chronic lymphocytic leukemia (2), malaria (1), diffuse infiltrative lymphocytosis syndrome (1), penicilliosis (1), leukemia, acute promyelocytic, somatic (1)
Comparative Toxicogenomics Database (CTD)
Common Gene Haplotype Alleles
Press "+" in the title bar above to open this section.
RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
Microarray Expression Data
Press "+" in the title bar above to open this section.
mRNA Secondary Structure of 3' and 5' UTRs
The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.
Protein Domain and Structure Information
InterPro Domains: Graphical view of domain structure IPR013517 - FG-GAP
IPR013519 - Int_alpha_beta-p
IPR000413 - Integrin_alpha
IPR013649 - Integrin_alpha-2
IPR018184 - Integrin_alpha_C_CS
IPR002035 - VWF_A
Pfam Domains: PF00092 - von Willebrand factor type A domain
PF00357 - Integrin alpha cytoplasmic region
PF01839 - FG-GAP repeat
PF08441 - Integrin alpha
PF13519 - von Willebrand factor type A domain
SCOP Domains: 69179 - Integrin domains
69318 - Integrin alpha N-terminal domain
53300 - vWA-like
Protein Data Bank (PDB) 3-D Structure
ModBase Predicted Comparative 3D Structure on P20701
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.
Orthologous Genes in Other Species
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Gene Ontology (GO) Annotations with Structured Vocabulary
Descriptions from all associated GenBank mRNAs
AX794822 - Sequence 19 from Patent WO03051924.AX794826 - Sequence 23 from Patent WO03051924.AK314246 - Homo sapiens cDNA, FLJ94991, highly similar to Homo sapiens integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) (ITGAL), mRNA.BC008777 - Homo sapiens integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide), mRNA (cDNA clone MGC:1714 IMAGE:3142951), complete cds.AX794824 - Sequence 21 from Patent WO03051924.AK298674 - Homo sapiens cDNA FLJ56671 complete cds, highly similar to Integrin alpha-L precursor.AX794810 - Sequence 7 from Patent WO03051924.Y00796 - Human mRNA for leukocyte-associated molecule-1 alpha subunit (LFA-1 alpha subunit).AK303190 - Homo sapiens cDNA FLJ57691 complete cds, highly similar to Integrin alpha-L precursor.AX794821 - Sequence 18 from Patent WO03051924.JD025405 - Sequence 6429 from Patent EP1572962.JD207020 - Sequence 188044 from Patent EP1572962.JD029251 - Sequence 10275 from Patent EP1572962.CU679099 - Synthetic construct Homo sapiens gateway clone IMAGE:100020539 5' read ITGAL mRNA.JD029840 - Sequence 10864 from Patent EP1572962.JD020193 - Sequence 1217 from Patent EP1572962.JD029384 - Sequence 10408 from Patent EP1572962.AX794814 - Sequence 11 from Patent WO03051924.AX794827 - Sequence 24 from Patent WO03051924.AX794823 - Sequence 20 from Patent WO03051924.AX794813 - Sequence 10 from Patent WO03051924.AX794820 - Sequence 17 from Patent WO03051924.AX794811 - Sequence 8 from Patent WO03051924.AX794819 - Sequence 16 from Patent WO03051924.AX794818 - Sequence 15 from Patent WO03051924.AX794812 - Sequence 9 from Patent WO03051924.AX794825 - Sequence 22 from Patent WO03051924.JD493402 - Sequence 474426 from Patent EP1572962.JD389096 - Sequence 370120 from Patent EP1572962.JD189711 - Sequence 170735 from Patent EP1572962.JD257146 - Sequence 238170 from Patent EP1572962.JD210824 - Sequence 191848 from Patent EP1572962.JD131948 - Sequence 112972 from Patent EP1572962.JD548031 - Sequence 529055 from Patent EP1572962.JD535815 - Sequence 516839 from Patent EP1572962.JD453130 - Sequence 434154 from Patent EP1572962.JD533435 - Sequence 514459 from Patent EP1572962.JD287273 - Sequence 268297 from Patent EP1572962.JD493835 - Sequence 474859 from Patent EP1572962.JD204371 - Sequence 185395 from Patent EP1572962.JD450926 - Sequence 431950 from Patent EP1572962.JD158250 - Sequence 139274 from Patent EP1572962.JD541160 - Sequence 522184 from Patent EP1572962.JD208531 - Sequence 189555 from Patent EP1572962.JD329432 - Sequence 310456 from Patent EP1572962.JD195338 - Sequence 176362 from Patent EP1572962.JD527284 - Sequence 508308 from Patent EP1572962.JD364804 - Sequence 345828 from Patent EP1572962.JD390651 - Sequence 371675 from Patent EP1572962.JD391911 - Sequence 372935 from Patent EP1572962.JD551810 - Sequence 532834 from Patent EP1572962.JD508069 - Sequence 489093 from Patent EP1572962.JD045080 - Sequence 26104 from Patent EP1572962.JD278282 - Sequence 259306 from Patent EP1572962.HZ483118 - JP 2015535430-A/3624: TERMINALLY MODIFIED RNA.HZ793049 - JP 2016504050-A/4794: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.JC515781 - Sequence 6034 from Patent WO2014113089.LQ073369 - Sequence 3693 from Patent EP2964234.JD140170 - Sequence 121194 from Patent EP1572962.JD481205 - Sequence 462229 from Patent EP1572962.JD179301 - Sequence 160325 from Patent EP1572962.JD380874 - Sequence 361898 from Patent EP1572962.JD380875 - Sequence 361899 from Patent EP1572962.JD446357 - Sequence 427381 from Patent EP1572962.JD499242 - Sequence 480266 from Patent EP1572962.JD376757 - Sequence 357781 from Patent EP1572962.JD410121 - Sequence 391145 from Patent EP1572962.JD447034 - Sequence 428058 from Patent EP1572962.JD177541 - Sequence 158565 from Patent EP1572962.JD177540 - Sequence 158564 from Patent EP1572962.JD361182 - Sequence 342206 from Patent EP1572962.JD366340 - Sequence 347364 from Patent EP1572962.JD116941 - Sequence 97965 from Patent EP1572962.JD401914 - Sequence 382938 from Patent EP1572962.JD401915 - Sequence 382939 from Patent EP1572962.JD365966 - Sequence 346990 from Patent EP1572962.JD110997 - Sequence 92021 from Patent EP1572962.JD247075 - Sequence 228099 from Patent EP1572962.JD042094 - Sequence 23118 from Patent EP1572962.JD229912 - Sequence 210936 from Patent EP1572962.MA646870 - JP 2017113010-A/4794: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.MA734754 - JP 2017140048-A/3624: TERMINALLY MODIFIED RNA.MA803923 - JP 2018183181-A/4794: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
Biochemical and Signaling Pathways
Other Names for This Gene
Alternate Gene Symbols: CD11A, ENST00000356798.1, ENST00000356798.10, ENST00000356798.2, ENST00000356798.3, ENST00000356798.4, ENST00000356798.5, ENST00000356798.6, ENST00000356798.7, ENST00000356798.8, ENST00000356798.9, ITAL_HUMAN, ITGAL , NM_002209, O43746, P20701, Q45H73, Q96HB1, Q9UBC8, uc317zsr.1, uc317zsr.2UCSC ID: ENST00000356798.11_4RefSeq Accession: NM_002209.3
Protein: P20701
(aka ITAL_HUMAN)
Gene Model Information
Click here
for a detailed description of the fields of the table above.
Methods, Credits, and Use Restrictions
Click here
for details on how this gene model was made and data restrictions if any.